Search

everythinglearnresearchcommunity

for

Search:↓

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Recent advances in hair loss treatments show significant progress.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hair loss in postmenopausal woman caused by ovarian issue.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Skin cell-derived vesicles can help heal skin injuries effectively.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

A dog fully recovered from minoxidil poisoning after receiving treatment.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.